The anti-protozoal drug pentamidine is active against opportunistic Pneumocystis pneumonia, but in addition has several other biological targets, including the NMDA receptor (NR). Here we describe the inhibitory potencies of 76 pentamidine analogs at 2 binding sites of the NR, the channel binding site labeled with [(3)H]MK-801 and the [(3)H]ifenprodil binding site. Most analogs acted weaker at the ifenprodil than at the channel site. The spermine-sensitivity of NR inhibition by the majority of the compounds was reminiscent of other long-chain dicationic NR blockers. The potency of the parent compound as NR blocker was increased by modifying the heteroatoms in the bridge connecting the 2 benzamidine moieties and also by integrating the bridge into a seven-membered ring. Docking of the 45 most spermine-sensitive bisbenzamidines to a recently described acidic interface between the N-terminal domains of GluN1 and GluN2B mediating polyamine stimulation of the NR revealed the domain contributed by GluN1 as the most relevant target.
The anti-protozoal drug pentamidine is active agan class="Chemical">inst opportunistic Pneumocystis pneumonia, but in addition has several other biological targets, including the NMDA receptor (NR). Here we describe the inhibitory potencies of 76 pentamidine analogs at 2 binding sites of the NR, the channel binding site labeled with [(3)H]MK-801 and the [(3)H]ifenprodil binding site. Most analogs acted weaker at the ifenprodil than at the channel site. The spermine-sensitivity of NR inhibition by the majority of the compounds was reminiscent of other long-chain dicationic NR blockers. The potency of the parent compound as NR blocker was increased by modifying the heteroatoms in the bridge connecting the 2 benzamidine moieties and also by integrating the bridge into a seven-membered ring. Docking of the 45 most spermine-sensitive bisbenzamidines to a recently described acidic interface between the N-terminal domains of GluN1 and GluN2B mediating polyamine stimulation of the NR revealed the domaincontributed by GluN1 as the most relevant target.
Authors: Michael L Berger; Abdallah Y Bitar; Matthew J Waitner; Patrick Rebernik; Mary C O'Sullivan Journal: Bioorg Med Chem Lett Date: 2006-03-24 Impact factor: 2.823
Authors: Sirish Mallena; Michael P H Lee; Christian Bailly; Stephen Neidle; Arvind Kumar; David W Boykin; W David Wilson Journal: J Am Chem Soc Date: 2004-10-27 Impact factor: 15.419
Authors: Tien L Huang; Jean Jacques Vanden Eynde; Annie Mayence; Margaret S Collins; Melanie T Cushion; Donna Rattendi; Indira Londono; Lakshman Mazumder; Cyrus J Bacchi; Nigel Yarlett Journal: Bioorg Med Chem Lett Date: 2009-08-23 Impact factor: 2.823
Authors: Manoj Munde; Mohamed A Ismail; Reem Arafa; Paul Peixoto; Catharine J Collar; Yang Liu; Laixing Hu; Marie-Hélène David-Cordonnier; Amélie Lansiaux; Christian Bailly; David W Boykin; W David Wilson Journal: J Am Chem Soc Date: 2007-10-13 Impact factor: 15.419
Authors: Lucas C Armstrong; Glenn E Kirsch; Nikolai B Fedorov; Caiyun Wu; Yuri A Kuryshev; Abby L Sewell; Zhiqi Liu; Arianne L Motter; Carmine S Leggett; Michael S Orr Journal: SLAS Discov Date: 2017-03-15 Impact factor: 3.341